Bryan Mehlhaff, MD, medical director of research for Oregon Urology Institute, discusses the ways in which the treatment landscape in prostate cancer has evolved in recent years.
Bryan A. Mehlhaff, MD
Advertisement
Articles by Bryan A. Mehlhaff, MD
Bryan A. Mehlhaff, MD, from the Oregon Urology Institute, discusses prostate cancer screening guidelines.
Advertisement
Latest Updated Articles
Dr. Mehlhaff on the Evolution of the Treatment Landscape in Prostate CancerPublished: January 10th 2017 | Updated:
Dr. Mehlhaff on Prostate Cancer Screening GuidelinesPublished: January 16th 2014 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Accepts BLA for Ivonescimab Plus Chemotherapy in EGFR-Mutant NSCLC After TKI Progression
2
FDA Approval Sought for Lirafugratinib in Second-Line, FGFR2-Altered Cholangiocarcinoma
3
Dr Spencer on First-Line Chemo Selection in Metastatic Pancreatic Adenocarcinoma
4
2025 Data Across Gynecologic, Lung, and Hematologic Cancers Reshape Treatment Landscapes
5